- Home
- Blair James C
Insider Trading History of Blair James C
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Blair James C since 2005.
The trader's CIK number is 1024000.
At the time of the last reporting, Blair James C was the 10% Owner of Clovis Oncology, Inc.. (stock ticker symbol CLVS).
Also see all insider trading activities at Clovis Oncology, Inc..
Note that in the past
BLAIR JAMES C also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Esperion Therapeutics, Inc. (ESPR) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | ESPR | 285,714 | $3,999,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Paratek Pharmaceuticals, Inc. (NOVC) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | NOVC | 0 | $0 | 250,000 | $238,755 | 0 | $0 |
2007 | NOVC | 0 | $0 | 24,500 | $275,870 | 0 | $0 |
2006 | NOVC | 461,538 | $2,999,997 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Somaxon Pharmaceuticals, Inc. (SOMX) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | SOMX | 0 | $0 | 12,918 | $171,485 | 0 | $0 |
Yearly summary of insider trading at Volcano Corp (VOLC) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2008 | VOLC | 0 | $0 | 36,189 | $498,961 | 0 | $0 |
2007 | VOLC | 0 | $0 | 25,247 | $486,004 | 0 | $0 |
2006 | VOLC | 0 | $0 | 1,508,249 | $25,263,170 | 0 | $0 |
Yearly summary of insider trading at Durata Therapeutics, Inc. (DRTX) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | DRTX | 784,313 | $7,058,817 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alimera Sciences Inc (ALIM) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | ALIM | 0 | $0 | 6,914 | $55,588 | 0 | $0 |
2010 | ALIM | 378,028 | $4,158,308 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nuvasive Inc (NUVA) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | NUVA | 0 | $0 | 8,919 | $213,119 | 0 | $0 |
2005 | NUVA | 0 | $0 | 336,285 | $5,659,077 | 0 | $0 |
Yearly summary of insider trading at Clovis Oncology, Inc. (CLVS) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | CLVS | 40,000 | $233,400 | 17,056 | $473,986 | 0 | $0 |
2017 | CLVS | 0 | $0 | 18,450 | $1,450,354 | 0 | $0 |
2015 | CLVS | 0 | $0 | 8,528 | $662,625 | 0 | $0 |
2011 | CLVS | 931,683 | $12,111,879 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Regado Biosciences Inc (RGDO) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | RGDO | 750,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cadence Pharmaceuticals Inc (CADX) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | CADX | 2,780,674 | $19,826,205 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pharmion Corp (PHRM) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | PHRM | 1,031,600 | $19,663,516 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zogenix, Inc. (ZGNX) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | ZGNX | 3,500,000 | $7,000,000 | 0 | $0 | 0 | $0 |
2010 | ZGNX | 2,349,999 | $9,399,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Reva Medical, Inc. (RVA) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | RVA | 0 | $0 | 1,695,717 | $8,749,899 | 0 | $0 |
Yearly summary of insider trading at Orexigen Therapeutics, Inc. (OREX) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | OREX | 469,147 | $680,263 | 0 | $0 | 0 | $0 |
2009 | OREX | 2,058,610 | $15,303,325 | 0 | $0 | 0 | $0 |
2008 | OREX | 490,301 | $2,302,914 | 0 | $0 | 0 | $0 |
2007 | OREX | 525,000 | $6,300,000 | 21,000 | $299,670 | 0 | $0 |
Yearly summary of insider trading at Vanda Pharmaceuticals Inc. (VNDA) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | VNDA | 0 | $0 | 12,900 | $330,498 | 0 | $0 |
Yearly summary of insider trading at Tranzyme Inc (OCRX) by Blair James C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | OCRX | 1,327,491 | $7,999,460 | 0 | $0 | 0 | $0 |
Insider trading activities at 16 companies by Blair James C:
1. Esperion Therapeutics, Inc. (ESPR)
2. Paratek Pharmaceuticals, Inc. (NOVC)
3. Somaxon Pharmaceuticals, Inc. (SOMX)
4. Volcano Corp (VOLC)
5. Durata Therapeutics, Inc. (DRTX)
6. Alimera Sciences Inc (ALIM)
7. Nuvasive Inc (NUVA)
8. Clovis Oncology, Inc. (CLVS)
9. Regado Biosciences Inc (RGDO)
10. Cadence Pharmaceuticals Inc (CADX)
11. Pharmion Corp (PHRM)
12. Zogenix, Inc. (ZGNX)
13. Reva Medical, Inc. (RVA)
14. Orexigen Therapeutics, Inc. (OREX)
15. Vanda Pharmaceuticals Inc. (VNDA)
16. Tranzyme Inc (OCRX)
Table 1. Insider trading of Esperion Therapeutics, Inc. (ESPR) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-07-01 | ESPR | Buy | 285,714 | 14.00 | 3,999,996 |
Table 2. Insider trading of Paratek Pharmaceuticals, Inc. (NOVC) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-01-28 | NOVC | Sale | 36,700 | .93 | 34,131 |
2009-01-29 | NOVC | Sale | 63,000 | .91 | 57,330 |
2009-01-30 | NOVC | Sale | 150,300 | .98 | 147,294 |
2007-06-06 | NOVC | Sale | 24,500 | 11.26 | 275,870 |
2006-05-15 | NOVC | Buy | 461,538 | 6.50 | 2,999,997 |
Table 3. Insider trading of Somaxon Pharmaceuticals, Inc. (SOMX) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-12-21 | SOMX | Sale | 6,459 | 13.52 | 87,325 |
2006-09-18 | SOMX | Sale | 6,459 | 13.03 | 84,160 |
Table 4. Insider trading of Volcano Corp (VOLC) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2008-07-16 | VOLC | Sale | 19,357 | 14.49 | 280,482 |
2008-04-08 | VOLC | Sale | 16,832 | 12.98 | 218,479 |
2007-05-18 | VOLC | Sale | 25,247 | 19.25 | 486,004 |
2006-12-06 | VOLC | Sale | 1,508,249 | 16.75 | 25,263,170 |
Table 5. Insider trading of Durata Therapeutics, Inc. (DRTX) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-07-24 | DRTX | Buy | 784,313 | 9.00 | 7,058,817 |
Table 6. Insider trading of Alimera Sciences Inc (ALIM) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-06-02 | ALIM | Sale | 6,914 | 8.04 | 55,588 |
2010-04-27 | ALIM | Buy | 378,028 | 11.00 | 4,158,308 |
Table 7. Insider trading of Nuvasive Inc (NUVA) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-12-06 | NUVA | Sale | 8,919 | 23.89 | 213,119 |
2005-11-16 | NUVA | Sale | 53,422 | 17.04 | 910,310 |
2005-11-14 | NUVA | Sale | 124,716 | 16.86 | 2,103,335 |
2005-11-10 | NUVA | Sale | 40,807 | 16.50 | 673,233 |
2005-11-04 | NUVA | Sale | 5,000 | 16.64 | 83,185 |
2005-11-03 | NUVA | Sale | 12,000 | 17.16 | 205,884 |
2005-11-03 | NUVA | Sale | 12,000 | 17.16 | 205,884 |
2005-11-02 | NUVA | Sale | 47,200 | 16.66 | 786,493 |
2005-11-01 | NUVA | Sale | 24,500 | 16.62 | 407,312 |
2005-08-16 | NUVA | Sale | 6,240 | 19.64 | 122,553 |
2005-06-09 | NUVA | Sale | 10,400 | 15.47 | 160,888 |
Table 8. Insider trading of Clovis Oncology, Inc. (CLVS) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-08-16 | CLVS | Buy | 20,000 | 5.70 | 114,000 |
2019-08-20 | CLVS | Buy | 20,000 | 5.97 | 119,400 |
2019-03-14 | CLVS | Sale | 17,056 | 27.79 | 473,986 |
2017-08-04 | CLVS | Sale | 18,450 | 78.61 | 1,450,354 |
2015-03-05 | CLVS | Sale | 8,528 | 77.70 | 662,625 |
2011-11-21 | CLVS | Buy | 931,683 | 13.00 | 12,111,879 |
Table 9. Insider trading of Regado Biosciences Inc (RGDO) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-08-27 | RGDO | Buy | 750,000 | 4.00 | 3,000,000 |
Table 10. Insider trading of Cadence Pharmaceuticals Inc (CADX) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-02-18 | CADX | Buy | 2,780,674 | 7.13 | 19,826,205 |
Table 11. Insider trading of Pharmion Corp (PHRM) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-06-09 | PHRM | Buy | 31,600 | 17.71 | 559,636 |
2006-05-03 | PHRM | Buy | 500,000 | 18.64 | 9,320,000 |
2006-05-04 | PHRM | Buy | 285,200 | 19.98 | 5,698,296 |
2006-05-02 | PHRM | Buy | 103,000 | 19.01 | 1,958,030 |
2006-05-01 | PHRM | Buy | 111,800 | 19.03 | 2,127,554 |
Table 12. Insider trading of Zogenix, Inc. (ZGNX) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-09-16 | ZGNX | Buy | 3,500,000 | 2.00 | 7,000,000 |
2010-11-29 | ZGNX | Buy | 2,349,999 | 4.00 | 9,399,996 |
Table 13. Insider trading of Reva Medical, Inc. (RVA) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-03-23 | RVA | Sale | 1,695,717 | 5.16 | 8,749,899 |
Table 14. Insider trading of Orexigen Therapeutics, Inc. (OREX) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-12-22 | OREX | Buy | 469,147 | 1.45 | 680,263 |
2009-12-18 | OREX | Buy | 38,100 | 7.50 | 285,750 |
2009-12-17 | OREX | Buy | 100,000 | 7.55 | 755,000 |
2009-11-24 | OREX | Buy | 50,000 | 6.75 | 337,500 |
2009-11-20 | OREX | Buy | 250,000 | 6.93 | 1,732,500 |
2009-11-23 | OREX | Buy | 150,000 | 6.93 | 1,039,500 |
2009-11-12 | OREX | Buy | 62,000 | 6.90 | 427,800 |
2009-11-11 | OREX | Buy | 53,600 | 6.93 | 371,448 |
2009-11-10 | OREX | Buy | 84,400 | 6.93 | 584,892 |
2009-08-18 | OREX | Buy | 13,784 | 7.73 | 106,550 |
2009-08-14 | OREX | Buy | 26,225 | 8.00 | 209,800 |
2009-08-17 | OREX | Buy | 63,201 | 7.64 | 482,855 |
2009-08-12 | OREX | Buy | 400,000 | 8.00 | 3,200,000 |
2009-08-13 | OREX | Buy | 13,000 | 7.85 | 102,050 |
2009-08-11 | OREX | Buy | 104,300 | 7.60 | 792,680 |
2009-07-23 | OREX | Buy | 650,000 | 7.50 | 4,875,000 |
2008-12-08 | OREX | Buy | 248,411 | 4.47 | 1,110,397 |
2008-12-09 | OREX | Buy | 241,890 | 4.93 | 1,192,517 |
2007-11-27 | OREX | Sale | 21,000 | 14.27 | 299,670 |
2007-05-01 | OREX | Buy | 525,000 | 12.00 | 6,300,000 |
Table 15. Insider trading of Vanda Pharmaceuticals Inc. (VNDA) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-12-12 | VNDA | Sale | 12,900 | 25.62 | 330,498 |
Table 16. Insider trading of Tranzyme Inc (OCRX) by Blair James C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-07-15 | OCRX | Buy | 1,327,491 | 6.03 | 7,999,460 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Blair James C
(10% Owner of Clovis Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.